- Home
- LUCD vs MRCC Comparison
LUCD vs MRCC Comparison
Compare LUCD & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LUCD | MRCC |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.4M | 141.3M |
| IPO Year | 2021 | 2012 |
Fundamental Metrics
Financial Performance| Metric | LUCD | MRCC |
|---|---|---|
| Price | $1.14 | $6.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $3.94 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 819.1K | 89.6K |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 11.04% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $4,399,000.00 | ★ $43,742,000.00 |
| Revenue This Year | $12.31 | N/A |
| Revenue Next Year | $152.14 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.01 | N/A |
| 52 Week Low | $0.75 | $5.86 |
| 52 Week High | $1.80 | $8.85 |
Technical Indicators
Market Signals| Indicator | LUCD | MRCC |
|---|---|---|
| Relative Strength Index (RSI) | 56.20 | 50.90 |
| Support Level | $1.09 | $6.20 |
| Resistance Level | $1.15 | $6.80 |
| Average True Range (ATR) | 0.05 | 0.17 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 83.12 | 59.22 |
Price Performance
Historical ComparisonAbout LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.